Management of Osteogenesis Imperfecta

por Ralston, Stuart H., Gaston, Mark S.
Publicado 2020

Paget’s disease of bone: when and why to refer to specialist care

por Nairn, Catherine, Ralston, Stuart H
Publicado 2020

Genetic Determinants of Paget’s Disease of Bone

por Makaram, Navnit S., Ralston, Stuart H.
Publicado 2021

Role of cannabinoids in the regulation of bone remodeling

por Idris, Aymen I., Ralston, Stuart H.
Publicado 2012

Clinical Features, Incidence and Treatment Outcome in Pregnancy-Associated Osteoporosis: A Single-Centre Experience over Two Decades

por Orhadje, Elizabeth, Berg, Kathryn, Hauser, Barbara, Ralston, Stuart H.
Publicado 2023

Antibody Response to Paramyxoviruses in Paget’s Disease of Bone

por Visconti, Micaela Rios, Usategui-Martín, Ricardo, Ralston, Stuart H.
Publicado 2017

Mind the gaps: therapists’ experiences of managing symptomatic hypermobility in Scotland

por Dockrell, Dervil M, Berg, Kathryn M, Ralston, Stuart H
Publicado 2021

Epigenetic analysis of Paget’s disease of bone identifies differentially methylated loci that predict disease status

por Diboun, Ilhame, Wani, Sachin, Ralston, Stuart H, Albagha, Omar ME
Publicado 2021

Epigenetic DNA Methylation Signatures Associated With the Severity of Paget’s Disease of Bone

por Diboun, Ilhame, Wani, Sachin, Ralston, Stuart H., Albagha, Omar M. E.
Publicado 2022

Probiotics Inhibit Cartilage Damage and Progression of Osteoarthritis in Mice

por Sophocleous, Antonia, Azfer, Asim, Huesa, Carmen, Stylianou, Eleni, Ralston, Stuart H.
Publicado 2022

Combined deficiency of the Cnr1 and Cnr2 receptors protects against age‐related bone loss by osteoclast inhibition

por Sophocleous, Antonia, Marino, Silvia, Kabir, Dilruba, Ralston, Stuart H., Idris, Aymen I.
Publicado 2017

Proton Pump Inhibitors Inhibit PHOSPHO1 Activity and Matrix Mineralisation In Vitro

por Staines, Katherine A., Myers, Katherine, Little, Kirsty, Ralston, Stuart H., Farquharson, Colin
Publicado 2021

Communicating Absolute Fracture Risk Reduction and the Acceptance of Treatment for Osteoporosis

por Ralston, Katherine A. P., Phillips, Jonathan, Krause, Amrey, Hauser, Barbara, Ralston, Stuart H.
Publicado 2022

A Class III Semaphorin (Sema3e) Inhibits Mouse Osteoblast Migration and Decreases Osteoclast Formation In Vitro

por Hughes, Alun, Kleine-Albers, Jennifer, Helfrich, Miep H., Ralston, Stuart H., Rogers, Michael J.
Publicado 2012

A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease

por Cronin, Owen, McKnight, Olivia, Keir, Lindsay, Ralston, Stuart H., Hirani, Nikhil, Harris, Helen
Publicado 2021

Adult hypophosphatasia with a novel ALPL mutation: Report of an Indian kindred

por Bhadada, Sanjay K., Pal, Rimesh, Dhiman, Vandana, Alonso, Nerea, Ralston, Stuart H., Kaur, Simran, Gupta, Rajat
Publicado 2020

Correction to: Targeted Inactivation of Rin3 Increases Trabecular Bone Mass by Reducing Bone Resorption and Favouring Bone Formation

por Vallet, Mahéva, Sophocleous, Antonia, Törnqvist, Anna E., Azfer, Asim, Hof, Rob van’t, Albagha, Omar ME, Ralston, Stuart H.
Publicado 2021

Targeted Inactivation of Rin3 Increases Trabecular Bone Mass by Reducing Bone Resorption and Favouring Bone Formation

por Vallet, Mahéva, Sophocleous, Antonia, Törnqvist, Anna E., Azfer, Asim, Hof, Rob van’t, Albagha, Omar ME, Ralston, Stuart H.
Publicado 2021

The Paget's disease of bone risk gene PML is a negative regulator of osteoclast differentiation and bone resorption

por Wani, Sachin, Daroszewska, Anna, Salter, Donald M., van ‘t Hof, Rob J., Ralston, Stuart H., Albagha, Omar M. E.
Publicado 2022

Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62(P394L) mouse model of Paget's disease

por Daroszewska, Anna, Rose, Lorraine, Sarsam, Nadine, Charlesworth, Gemma, Prior, Amanda, Rose, Kenneth, Ralston, Stuart H., van ‘t Hof, Robert J.
Publicado 2018